Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old
NCT ID: NCT03881228
Last Updated: 2024-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
356 participants
INTERVENTIONAL
2019-12-01
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In September 2020, the protocol was updated to adapt to the COVID19 situation in Lima. One of the secondary outcome (isoniazid concentration in urine) was cancelled and the full intervention (educational booklet, weekly children storybook and weekly SMS) is now delivered through WhatsApp.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases
NCT03074799
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146
Community-based Tuberculosis Tracing and Preventive Therapy
NCT03832023
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
NCT07086820
Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya
NCT00850915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will assess the efficacy of the intervention by 1) measuring IPT completion at 6 months after treatment initiation. The secondary outcome originally planned (determining adherence to IPT by measuring isoniazid in urine at weeks 2, 8 and 24) has been cancelled in adaptation to the SARS Cov2 pandemic.
Fidelity, reach and acceptability will be measured among caretakers and staff with an in depth interview at the end of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
1. at enrollment, caretakers will receive an educational booklet for caretakers explaining why IPT needs to be given
2. at enrollment and weekly for 24 weeks, caretakers will receive a children's storybook, with weekly installments, over the 6-month course of IPT as a non-monetary incentive
3. weekly, caretakers will receive short messages services (SMS) reminders delivered to the caretaker for the weekly pick-up.
Increasing the completion of IPT
Behavioral intervention with three components to increase the completion of IPT among children
Standard of care
Routine care at the health facility
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Increasing the completion of IPT
Behavioral intervention with three components to increase the completion of IPT among children
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Peruana Cayetano Heredia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Larissa Otero, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Peruana Cayetano Heredia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto de Medicina Tropical Alexander von Humboldt
Lima, , Peru
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Otero L, Zetola N, Campos M, Zunt J, Bayer A, Curisinche M, Ochoa T, Reyes M, Vega V, Van der Stuyft P, Sterling TR. Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial. Trials. 2023 Jan 24;24(1):54. doi: 10.1186/s13063-022-07062-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
103161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.